Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic breakthroughs for metastatic thyroid cancer.

× No keyword cloud information.

8 in total

Review 1. Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers.

Authors: Faraat Ali; Kumari Neha; Garima Chauhan
Journal: Arch Pharm Res Date: 2022-05-22 Impact factor: 4.946

Review 2. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.

Authors: David C Shonka; Alan Ho; Ashish V Chintakuntlawar; Jessica L Geiger; Jong C Park; Nagashree Seetharamu; Sina Jasim; Amr H Abdelhamid Ahmed; Keith C Bible; Marcia S Brose; Maria E Cabanillas; Kirsten Dabekaussen; Louise Davies; Dora Dias-Santagata; James A Fagin; William C Faquin; Ronald A Ghossein; Raj K Gopal; Akira Miyauchi; Yuri E Nikiforov; Matthew D Ringel; Bruce Robinson; Mabel M Ryder; Eric J Sherman; Peter M Sadow; Jennifer J Shin; Brendan C Stack; R Michael Tuttle; Lori J Wirth; Mark E Zafereo; Gregory W Randolph
Journal: Head Neck Date: 2022-03-11 Impact factor: 3.821

3. Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue.

Authors: Aidana Amrenova; Keiji Suzuki; Vladimir Saenko; Shunichi Yamashita; Norisato Mitsutake
Journal: PLoS One Date: 2021-04-01 Impact factor: 3.240

4. Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer.

Authors: Xiaobo Zheng; Li Feng; Yunfan Yin; Chune Yu; Xiujing He; Jiao Zhu; Ming Zhang; Jing Yu; Mingqing Xu
Journal: Aging (Albany NY) Date: 2021-10-08 Impact factor: 5.682

5. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.

Authors: Linwen Zeng; Shaofeng Yuan; Pengfei Zhou; Jianming Gong; Xiangdong Kong; Ming Wu
Journal: Bioengineered Date: 2021-12 Impact factor: 3.269

6. Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines.

Authors: Francesca Maria Orlandella; Peppino Mirabelli; Anna Elisa De Stefano; Paola Lucia Chiara Iervolino; Neila Luciano; Stefania D'Angelo; Giuliana Salvatore
Journal: Oxid Med Cell Longev Date: 2022-02-17 Impact factor: 6.543

7. Editorial: The role of genetic alterations in thyroid carcinoma.

Authors: Joachim Feldkamp
Journal: Front Endocrinol (Lausanne) Date: 2022-08-23 Impact factor: 6.055

8. Increased diagnostic sensitivity of palpation-guided thyroid nodule fine-needle aspiration cytology by BRAF V600E-mutation analysis.

Authors: Oliver Gimm; Kristin Ivansson; Ervin Beka; Hugo M Rossitti; Stina Garvin; Peter Söderkvist
Journal: J Pathol Clin Res Date: 2021-06-22

8 in total